Dental implant suprastructure device, permanent Australia - English - Department of Health (Therapeutic Goods Administration)

dental implant suprastructure device, permanent

implant solutions pty ltd (trading as osteon medical) - 44879 - dental implant suprastructure device, permanent - a prefabricated device that is incorporated into, or creates, the necessary suprastructure mimicking preparations of natural teeth. it is used during dental implant restorative procedures and will provide the permanent intermediate fixture level between the dental implant and the final restoration (e.g., bridge, single tooth, overdenture)

Scanning dental implant abutment Australia - English - Department of Health (Therapeutic Goods Administration)

scanning dental implant abutment

implant solutions pty ltd (trading as osteon medical) - 61641 - scanning dental implant abutment - a non-sterile device used as temporary copy of a dental implant abutment in a patient to confirm the position of the final dental implant body during dental implant restorative procedures. it is used during a scanning procedure performed with a digital intraoral sensor.

Dental implant analog Australia - English - Department of Health (Therapeutic Goods Administration)

dental implant analog

implant solutions pty ltd (trading as osteon medical) - 61642 - dental implant analog - analogues are used to simulate the position, direction, and connection of an implant and, consequently, to facilitate the manufacture of dental prostheses in the laboratory.

Dental implant suprastructure, temporary, custom-made Australia - English - Department of Health (Therapeutic Goods Administration)

dental implant suprastructure, temporary, custom-made

implant solutions pty ltd (trading as osteon medical) - 64012 - dental implant suprastructure, temporary, custom-made - healing abutments are used to shape the gingival tissue during the healing process, to protect the connection and internal thread of the implant, and to protect the tongue from rubbing. they are placed on the implant prior to prosthetic restoration to facilitate soft tissue formation. healing abutment height is selected to guarantee its correct performance and to avoid the transmission of tension.

GLIADEL WAFER carmustine 7.7mg/implant implant sachet Australia - English - Department of Health (Therapeutic Goods Administration)

gliadel wafer carmustine 7.7mg/implant implant sachet

eisai australia pty ltd - carmustine, quantity: 7.7 mg - implant - excipient ingredients: polifeprosan - gliadel is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. gliadel is also indicated for use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme (gbm) for whom surgical resection is indicated.

IMPLANON NXT etonogestrel 68mg subcutaneous implant Australia - English - Department of Health (Therapeutic Goods Administration)

implanon nxt etonogestrel 68mg subcutaneous implant

organon pharma pty ltd - etonogestrel, quantity: 68 mg - implant - excipient ingredients: magnesium stearate; barium sulfate; vinyl acetate; octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate; isododecane; ethylene/vinyl acetate copolymer - contraception (removed and replaced every three years to ensure continued contraceptive efficacy)

OZURDEX dexamethasone 700 microgram intravitreal implant Australia - English - Department of Health (Therapeutic Goods Administration)

ozurdex dexamethasone 700 microgram intravitreal implant

abbvie pty ltd - dexamethasone, quantity: 700 microgram - implant - excipient ingredients: polyglactin - ozurdex is indicated for the treatment of:,- diabetic macular oedema (dme),- macular oedema due to branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).,- non-infectious uveitis affecting the posterior segment of the eye. ozurdex is indicated for the treatment of diabetic macular oedema (dme).

SCENESSE afamelanotide (as acetate) 16 mg implant vial Australia - English - Department of Health (Therapeutic Goods Administration)

scenesse afamelanotide (as acetate) 16 mg implant vial

clinuvel pharmaceuticals ltd - afamelanotide acetate, quantity: 18 mg - implant - excipient ingredients: polyglactin - scenesse is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (epp)

Dental implant suprastructure device, permanent Australia - English - Department of Health (Therapeutic Goods Administration)

dental implant suprastructure device, permanent

implant solutions pty ltd (trading as osteon medical) - 44879 - dental implant suprastructure device, permanent - intended to fix a prosthetic element to a dental implant.